Description
Product details
GLYCOPRESS INDUS™ is a modern dual bronchodilator therapy formulated with Indacaterol Maleate and Glycopyrronium Bromide, designed for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). This advanced inhalation formulation combines two complementary mechanisms of action to deliver sustained airway relaxation, improved lung function, and enhanced breathing comfort. COPD is a progressive respiratory condition characterized by airflow limitation, chronic inflammation, and episodes of breathlessness. Effective management requires consistent bronchodilation to keep the airways open and reduce daily symptoms. GLYCOPRESS INDUS™ addresses this need through a once-daily maintenance approach that targets airway narrowing through dual pharmacological pathways. Manufactured under strict quality standards, GLYCOPRESS INDUS™ ensures reliable dosing, stability, and optimal pulmonary delivery when used with the recommended inhalation device. It is intended for regular use and not for the treatment of sudden breathing emergencies. Composition and Mechanism of Action GLYCOPRESS INDUS™ combines two long-acting bronchodilators: 1. Indacaterol Maleate (Long-Acting Beta2-Agonist – LABA) Indacaterol stimulates beta2-adrenergic receptors located in the smooth muscles of the airways. Activation of these receptors causes the muscles to relax, resulting in bronchodilation. This effect: Reduces airway resistance Improves airflow Decreases breathlessness Supports 24-hour bronchodilation Indacaterol is known for its rapid onset and prolonged duration of action, making it effective for once-daily therapy. 2. Glycopyrronium Bromide (Long-Acting Muscarinic Antagonist – LAMA) Glycopyrronium blocks muscarinic receptors in the bronchial smooth muscles. These receptors normally respond to acetylcholine, which causes airway constriction. By inhibiting this response, glycopyrronium: Prevents bronchospasm Reduces airway tightening Promotes sustained airway relaxation Dual-Action Advantage The combination of LABA and LAMA in GLYCOPRESS INDUS™ provides enhanced bronchodilation compared to either agent alone. While indacaterol actively relaxes airway muscles, glycopyrronium prevents them from tightening. This complementary action ensures comprehensive and sustained airway management. Indications and Uses GLYCOPRESS INDUS™ is indicated for: Maintenance treatment of chronic obstructive pulmonary disease (COPD) Chronic bronchitis management Emphysema management Long-term airflow limitation therapy It is important to understand that GLYCOPRESS INDUS™: Is not a rescue inhaler Should not be used for sudden acute bronchospasm Is not intended for primary asthma treatment unless prescribed by a physician Patients should always keep a short-acting bronchodilator available for emergency relief. Key Benefits of GLYCOPRESS INDUS™ 1. Once-Daily Dosing Convenience GLYCOPRESS INDUS™ is formulated for once-daily administration, improving adherence and simplifying treatment routines. 2. Dual Bronchodilation for Superior Airway Control The LABA + LAMA combination provides broader and more effective airway relaxation compared to single-agent therapy. 3. Rapid Onset with Sustained Effect Indacaterol provides quick bronchodilation, while glycopyrronium maintains airway openness for up to 24 hours. 4. Improved Lung Function Regular use can enhance lung performance parameters, such as improved airflow measurements and reduced air trapping. 5. Reduced Breathlessness Patients may experience decreased shortness of breath during physical activities, leading to greater independence. 6. Lower Frequency of COPD Exacerbations Consistent airway maintenance can help reduce the likelihood of flare-ups and hospital visits. 7. Enhanced Quality of Life Better breathing control contributes to improved sleep, increased exercise tolerance, and overall well-being. Dosage and Administration GLYCOPRESS INDUS™ should be used exactly as prescribed by a healthcare professional. General Administration Guidelines: Use once daily at the same time each day. Inhale using the provided inhalation device. Do not swallow capsules (if capsule-based system). Do not exceed the recommended dose. Follow inhaler technique instructions carefully. Proper inhalation technique is essential for effective drug delivery. Healthcare providers should demonstrate correct usage during initial prescription. Possible Side Effects While GLYCOPRESS INDUS™ is generally well tolerated, some individuals may experience side effects. Common Side Effects Dry mouth Cough Throat irritation Headache Nasal congestion Mild tremor Dizziness These symptoms are often mild and may diminish with continued use. Cardiovascular Effects Due to the beta2-agonist component (indacaterol), some patients may experience: Increased heart rate Palpitations Mild fluctuations in blood pressure Patients with pre-existing heart conditions should consult their physician before starting therapy. Anticholinergic Effects (from Glycopyrronium) Difficulty urinating Blurred vision Worsening of narrow-angle glaucoma Individuals with urinary retention or glaucoma should use caution. Rare but Serious Reactions Paradoxical bronchospasm (worsening breathing immediately after inhalation) Severe allergic reactions Significant cardiac rhythm disturbances Immediate medical attention should be sought if severe reactions occur. Precautions and Warnings Before starting GLYCOPRESS INDUS™, inform your healthcare provider if you have: Cardiovascular disease Arrhythmias Hypertension Hyperthyroidism Diabetes Seizure disorders Glaucoma Prostate enlargement Kidney impairment Drug Interactions Caution is required when using: Other long-acting beta2-agonists Other anticholinergic medications Beta-blockers Diuretics Certain antidepressants (e.g., MAO inhibitors) Always provide a complete list of medications and supplements to your healthcare provider. Who Should Use GLYCOPRESS INDUS™? GLYCOPRESS INDUS™ is ideal for: Adults with moderate to severe COPD Patients not adequately controlled on single bronchodilator therapy Individuals seeking a once-daily maintenance inhaler Patients requiring dual bronchodilation for improved symptom control It is not typically recommended for pediatric patients unless specifically directed by a healthcare professional. Integrating GLYCOPRESS INDUS™ into COPD Management For optimal results, GLYCOPRESS INDUS™ should be part of a comprehensive COPD management plan that includes: Smoking cessation Pulmonary rehabilitation programs Regular physical activity Balanced nutrition Scheduled medical follow-ups Adherence to therapy and routine monitoring significantly improve long-term outcomes. Storage Instructions Store at room temperature Protect from moisture and direct sunlight Keep in original packaging until use Keep out of reach of children Conclusion GLYCOPRESS INDUS™ (Indacaterol Maleate + Glycopyrronium Bromide) is a powerful dual bronchodilator designed to provide sustained airway control in individuals living with chronic obstructive pulmonary disease. By combining a long-acting beta2-agonist and a long-acting muscarinic antagonist, it offers comprehensive bronchodilation through two complementary pathways.
